| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.059 | 0.06 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.06 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.07 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.06 | 0.07 |